Pharmacy spend continues to be a dominant cost driver for purchasers, fueled by specialty drugs and high-demand therapies like GLP-1s. Employers and plans are deploying stricter utilization management, formulary changes, and contracting strategies to rein in costs. Pharmacy is no longer a siloed issue; it is central to benefit strategy.